The BASA Study: Breath Analysis for Severe Asthma Patients

Status Recruiting

Clinical Trial Summary

This study will evaluate the fluctuations of exhaled breath markers in patients with severe asthma on biologics. In the study, severe asthma patients will be followed up to 16 weeks monitoring lung function and inflammation through non-invasive technologies such as exhaled breath analysis (FeNO, GC-MS and EBC). A control group will be followed up to two weeks with the overall objective to indentify and evaluate the modifcations of markers of inflammation in patient under biologic treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05946421
Study type	Observational
Source	Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Contact	Stefania Principe, PhD
Phone	+393478087131
Email	stefaniaprincipe90@gmail.com
Status	Recruiting
Phase
Start date	July 4, 2023
Completion date	September 4, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05018299` - Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma	Phase 2
Recruiting	`NCT05472324` - Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.	Phase 2
Recruiting	`NCT04914078` - Severe Asthma Exacerbations and Mepolizumab Treatment
Completed	`NCT05576454` - Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects	Phase 1
Recruiting	`NCT04438408` - National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
Recruiting	`NCT04520165` - Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
Not yet recruiting	`NCT04463836` - Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA)
Enrolling by invitation	`NCT06421402` - K-HEALTH in AIR - Barcelona Pilot - Cohort
Recruiting	`NCT03377920` - Predictive Value of Spirometric PIF to Produce PIF Rate Needed for the Use of Current DPI's.	N/A
Recruiting	`NCT04565483` - Predictive Signature of Benralizumab Response	Phase 4
Recruiting	`NCT04045587` - International Severe Asthma Registry: Canadian Cohort
Completed	`NCT05616338` - Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)	N/A
Active, not recruiting	`NCT02038374` - Clinico-biological Correlation of Severe Asthma in Children	N/A
Active, not recruiting	`NCT02114034` - Cohort Analysis of Clinical and Biological Severe Childhood Asthma
Recruiting	`NCT06035289` - Register Schweres Asthma - German Asthma Net e.V.
Not yet recruiting	`NCT03532685` - Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up	N/A
Completed	`NCT03931954` - Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
Recruiting	`NCT03984253` - Swiss Severe Asthma Register
Recruiting	`NCT03435237` - Phenotyping Asthma for Bronchial Thermoplasty
Recruiting	`NCT03476109` - Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.	Phase 4